Skip to main content
. 2018 May 8;23:300–309. doi: 10.12659/AOT.907666

Table 4B.

The achievement of Tac target C0 level among patients with 2.5 mg/day starting dose.

BMI (kg/m2) n Dose C0 (ng/ml) P <5 ng/ml 5–8 ng/ml >8 ng/ml P
<18.5 2 2.5±0.0 7.8±3.7 0.532 0 (0.0%) 1 (50.0%) 1 (50.0%) 0.456
18.5–23.9 12 2.5±0.0 5.4±2.7 6 (50.0%) 5 (41.7%) 1 (8.3%)
≥24 1 2.5±0.0 4.8 1 (100.0%) 0 (0%) 0 (0%)